Obstetrics and Gynecology

Episodes 1-16 of 24

Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast Replay
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
0.75 credits
- Kristina Deligiannidis, MD
- Jennifer L. Payne, MD
0.75 credits
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
CME/CE Broadcast Replay
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
0.75 credits
- Joseph F. Goldberg, MD
- Roger McIntyre, MD
0.75 credits
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
MinuteCE®
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
The Integral Role of GnRH Antagonists in the Management of Endometriosis
The Integral Role of GnRH Antagonists in the Management of Endometriosis
MinuteCE®
The Integral Role of GnRH Antagonists in the Management of Endometriosis
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
MinuteCE®
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
1.75 credits 10 episodes
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
- Melissa Simon, MD
- Samantha Denäe
- Casey Joe Hinds
1.75 credits 10 episodes
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®
Strategies to Address Healthcare Disparities in Patients With Endometriosis
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
1.75 program credits
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
CME/CE
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
0.50 credits
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
MinuteCE®
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
- Samantha Denäe
1.75 program credits
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
CME/CE
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
0.50 credits
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Clinical Considerations for the Diagnosis of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
1.75 program credits
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
MinuteCE®
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
- Casey Joe Hinds
1.75 program credits
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
MinuteCE®
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
1.75 program credits
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
CME/CE
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Sawsan As-Sanie, MD
- Linda Bradley, MD
0.25 credits
Pre- and Postoperative Use of GnRH Antagonists
Pre- and Postoperative Use of GnRH Antagonists
MinuteCE®
Pre- and Postoperative Use of GnRH Antagonists
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
MinuteCE®
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits

1/2

Episodes 1-16 of 24

Title

Share on ReachMD